Search results
Results From The WOW.Com Content Network
Autonomic features are involuntary physical symptoms usually caused by an overactive nervous system, such as panic attacks or intestinal distress. [1] The World Health Organization's ICD-10 describes Mixed anxiety and depressive disorder: "...when symptoms of anxiety and depression are both present, but neither is clearly predominant, and ...
Many people with panic disorder have a mixture of full blown and limited symptom attacks. LSAs often manifest in anxiety disorders, phobias, panic disorder and agoraphobia. However, experiencing an LSA is not necessarily indicative of mental illness. Often persons recovering from or being treated for panic attacks and panic disorder will ...
Panic disorder is a mental and behavioral disorder, [5] specifically an anxiety disorder characterized by reoccurring unexpected panic attacks. [1] Panic attacks are sudden periods of intense fear that may include palpitations , sweating, shaking, shortness of breath , numbness, or a feeling that something terrible is going to happen.
[50] [21] The focus on management of panic disorder involves reducing the frequency and intensity of panic attacks, reducing anticipatory anxiety and agoraphobia, and achieving full remission. [ 51 ] If a patient is experiencing a panic attack, most will resolve spontaneously within a course of 20 to 30 minutes without interference.
The DSM-IV-TR is a text revision of the DSM-IV. [1] While no new disorders were added in this version, 11 subtypes were added and 8 were removed. This list features both the added and removed subtypes. Also, 22 ICD-9-CM codes were updated. [2] The ICD codes stated in the first column are those from the DSM-IV-TR.
The Panic and Agoraphobia Scale (PAS) is primarily used for monitoring the efficacy of both medication and psychotherapy treatments of agoraphobia, as well as a screening tool for the disorder. It is available in both self-rated and clinician-rated versions and the scale structure is compatible with DSM-IV and ICD-10 classifications.
MDMA (Midomafetamine, 3,4-methylenedioxymethamphetamine, "ecstasy") – serotonin–norepinephrine–dopamine releasing agent and 5-HT 1 and 5-HT 2 receptor agonist – specifically under development as an aid to psychotherapy for post-traumatic stress disorder [14] [15] [16] NBTX-001 – NMDA receptor antagonist [17]
Caffeine-induced anxiety disorder is a subclass of the DSM-5 diagnosis of substance/medication-induced anxiety disorder. [1] Consumption of caffeine has long been linked to anxiety. [2] The effects of caffeine and the symptoms of anxiety both increase activity within the sympathetic nervous system.